AI-generated summary
The authors report on one patient with a moderate sleep-phase advance syndrome, who showed an early temperature and cortisol minimum before midnight. Evening light therapy at 2500 Lux over 17 months was associated with complete remission of symptoms, and the benefit was maintained after daily treatment ended, with only sporadic later use.
- Who or what was studied
- One patient with a moderate form of sleep-phase advance syndrome
- Limits stated in the abstract
- This is a single case report, so the findings cannot be generalized to other patients and no control group is described.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Case report, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.